Cole–Carpenter syndrome is an extremely rare autosomal recessive medical condition in humans. The condition affects less than 10 people worldwide. It is characterised by dysmorphic features and a tendency to fractures.
Signs and symptoms
This condition is usually diagnosed in infancy.
Features of this condition include: Short trunk Poor growth Hydrocephalus Multiple fractures Craniofacial abnormalities Multisutural craniosynostosis Ocular proptosis Marked frontal bossing Midface hypoplasia Micrognathia
Genetics
There are three forms of this syndrome.
Type 1 has mutations in the protein disulfide-isomerase (P4HB) gene located on the long arm of chromosome 17 (17q25).
Type 2 have mutations in the protein transport protein Sec24D (SEC24D) gene located on the long arm of chromosome 4 (4q26).
A third type has been described with a mutation in the cartilage associated protein (CRTAP) located on the short arm of chromosome 3 (3p22.3).
Clinically these forms are very similar and are best differentiated by gene sequencing.
The third patient (first female) diagnosed with this condition, gene sequencing shows no abnormalities.
Pathogensis
Protein disulfide-isomerase is involved in the hydroxylation of proline residues in preprocollagen. Protein transport protein Sec24D is a protein involved in vesicle transport. How mutations in the gene cause disease is not yet clear. Cartilage associated protein is involved in post translation modifications of collagen.
Diagnosis
The diagnosis may be suspected on the basis of the constellation of clinical features. It is made by sequencing the P4HB, SEC24D and CRTAP genes.
Differential diagnosis
Pfeiffer syndrome
Osteogenesis imperfecta
Osteoglophonic dwarfism
Treatment
There is no specific treatment for this condition currently known and management of its various features is the norm.
History
This condition was first described in 1987.